Get updated on the management of dyslipidemia in this replay of the Cardiometabolic & Venous diseases Forum, including discussions on ESC guidelines, latest evidence, and future perspectives in dyslipidemia management.
Discover Servier's symposium on Type 2 Diabetes at the IDF Congress 22, presenting for the first time new real-world evidence of the ADD2DIA Study and a new subanalysis of real-world study using JADE Register.
Learn more about the retrospective study comparing the effectiveness of gliclazide MR 60 mg versus sitagliptin as second-line treatment after metformin monotherapy in patients with uncontrolled T2D.
